Search Results - "Adenov, Malik"

Pregnancy and Birth Outcomes in Patients With Multidrug-Resistant Tuberculosis Treated With Regimens That Include New and Repurposed Drugs by Lotia Farrukh, Ismat, Lachenal, Nathalie, Adenov, Malik M, Ahmed, Saman, Algozhin, Yerkebulan, Coutisson, Sylvine, Garavito, Epifanio Sánchez, Hewison, Catherine, Holtzman, David, Huerga, Helena, Janmohamed, Aleeza, Khan, Palwasha Y, Jacques, Gamarly Leblanc, Lomtadze, Nino, Melikyan, Nara, Mitnick, Carole D, Mussabekova, Gulnaz, Osso, Elna, Perea, Sara, Putri, Fauziah Asnely, Rashidov, Mahmud, Rich, Michael L, Sakhabutdinova, Yekaterina, Seung, Kwonjune J, Stambekova, Assel, Vásquez, Dante Vargas, Franke, Molly F, Khan, Uzma

“…Among 43 pregnant women receiving multidrug-resistant/rifampicin-resistant tuberculosis (MDR/RR-TB) treatment with bedaquiline and/or delamanid, 98% had…”
Get full text

Culture conversion at six months in patients receiving bedaquiline- and delamanid-containing regimens for the treatment of multidrug-resistant tuberculosis by Maretbayeva, Shynar M., Rakisheva, Anar S., Adenov, Malik M., Yeraliyeva, Lyazzat T., Algozhin, Yerkebulan Zh, Stambekova, Assel T., Berikova, Elmira A., Yedilbayev, Askar, Rich, Michael L., Seung, Kwonjune J., Issayeva, Assiya M.

“…•Globally and in Kazakhstan, the uptake of bedaquiline and delamanid has been slow.•Bedaquiline and delamanid represent new classes anti-TB drugs.•Bedaquiline…”
Get full text

Corrigendum to ‘Culture conversion at six months in patients receiving bedaquiline- and delamanid-containing regimens for the treatment of multidrug-resistant tuberculosis’ International Journal of Infectious Diseases Volume 113S1 (2021) S91-S95 by Maretbayeva, Shynar M., Rakisheva, Anar S., Adenov, Malik M., Yeraliyeva, Lyazzat T., Algozhin, Yerkebulan Zh, Stambekova, Assel T., Berikova, Elmira A., Yedilbayev, Askar, Rich, Michael L., Seung, Kwonjune J., Issayeva, Assiya M.

Get full text

Safety of Treatment Regimens Containing Bedaquiline and Delamanid in the endTB Cohort by Hewison, Catherine, Khan, Uzma, Bastard, Mathieu, Lachenal, Nathalie, Coutisson, Sylvine, Osso, Elna, Ahmed, Saman, Khan, Palwasha, Franke, Molly F, Rich, Michael L, Varaine, Francis, Melikyan, Nara, Seung, Kwonjune J, Adenov, Malik, Adnan, Sana, Danielyan, Narine, Islam, Shirajul, Janmohamed, Aleeza, Karakozian, Hayk, Kamene Kimenye, Maureen, Kirakosyan, Ohanna, Kholikulov, Begimkul, Krisnanda, Aga, Kumsa, Andargachew, Leblanc, Garmaly, Lecca, Leonid, Nkuebe, Mpiti, Mamsa, Shahid, Padayachee, Shrivani, Thit, Phone, Mitnick, Carole D, Huerga, Helena

“…Abstract Background Safety of treatment for multidrug-resistant tuberculosis (MDR/RR-TB) can be an obstacle to treatment completion. Evaluate safety of longer…”
Get full text

Effectiveness and safety of modified fully oral 9-month treatment regimens for rifampicin-resistant tuberculosis: a prospective cohort study by Korotych, Oleksandr, Achar, Jay, Gurbanova, Elmira, Hovhannesyan, Arax, Lomtadze, Nino, Ciobanu, Ana, Skrahina, Alena, Dravniece, Gunta, Kuksa, Liga, Rich, Michael, Khachatryan, Naira, Germanovych, Myroslava, Kadyrov, Abdullat, Terleieva, Iana, Akhundova, Irada, Adenov, Malik, Durdyeva, Myahri, Kiria, Nana, Parpieva, Nargiza, Yatskevich, Natalia, Jumayev, Rovshen, Nurov, Rustam, Diktanas, Saulius, Vilc, Valentina, Migliori, Giovanni Battista, Yedilbayev, Askar

“…In 2020, WHO guidelines prioritised the use of a standard fully oral short treatment regimen (STR) consisting of bedaquiline, levofloxacin or moxifloxacin,…”
Get full text

HIV and multidrug-resistant tuberculosis: overlapping risk factors by van den Hof, Susan, Tursynbayeva, Aigul, Abildaev, Tleukhan, Adenov, Malik, Pak, Svetlana, Ismailov, Shakhimurat

“…Recent meta-analyses have indicated that, on average, new HIV-positive tuberculosis (TB) patients are at increased risk of multidrug-resistant (MDR)-TB…”
Get full text